Los Angeles Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.35M | Buy |
|
|||||
|
2025
Q2 | $887K | Sell |
|
|||||
|
2025
Q1 | $760K | Buy |
|
|||||
|
2024
Q4 | $761K | Buy |
|
|||||
|
2024
Q3 | $658K | Sell |
|
|||||
|
2024
Q2 | $603K | Buy |
|
|||||
|
2024
Q1 | $455K | Buy |
|
|||||
|
2023
Q4 | $319K | Buy |
|
|||||
|
2023
Q3 | $235K | Buy |
|
|||||
|
2023
Q2 | $230K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $180K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $315K | Sell |
|
|||||
|
2020
Q4 | $1.33M | Buy |
|
|||||
|
2020
Q3 | $445K | Buy |
|
|||||
|
2020
Q2 | $395K | Sell |
|
|||||
|
2020
Q1 | $238K | Buy |
|
|||||
|
2019
Q4 | $307K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $132K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $116K | Buy |
|